Disclosure 0001628280-26-058664-1

SEC FORM 4

$0.00

Crinetics Pharmaceuticals, Inc. (CRNX)

Acquisition (code A) of 471 shares at $0 per share.

Reporting Person Schilke Tobin · Officer Title Chief Financial & Infra. Ofcr. · Transaction Code A

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058664 · filed 2026-08-24 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Crinetics Pharmaceuticals, Inc. (CRNX)." Disclosed 2026-08-24. https://desqlong.com/cards/0001628280-26-058664-1 (retrieved 2026-09-26).